ZA200604365B - Compositions and methods for the diagnosis and treatment of tumor - Google Patents

Compositions and methods for the diagnosis and treatment of tumor

Info

Publication number
ZA200604365B
ZA200604365B ZA200604365A ZA200604365A ZA200604365B ZA 200604365 B ZA200604365 B ZA 200604365B ZA 200604365 A ZA200604365 A ZA 200604365A ZA 200604365 A ZA200604365 A ZA 200604365A ZA 200604365 B ZA200604365 B ZA 200604365B
Authority
ZA
South Africa
Prior art keywords
tumor
diagnosis
compositions
treatment
methods
Prior art date
Application number
ZA200604365A
Other languages
English (en)
Inventor
Ashkenazi Avi
Goddard Audrey
Gurney Austin
Polakis Paul
Smith Victoria
William I Wood
Wu Thomas
Zhang Zemin
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA200604365B publication Critical patent/ZA200604365B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200604365A 2003-11-20 2004-11-17 Compositions and methods for the diagnosis and treatment of tumor ZA200604365B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52385603P 2003-11-20 2003-11-20

Publications (1)

Publication Number Publication Date
ZA200604365B true ZA200604365B (en) 2008-01-30

Family

ID=34632836

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200604365A ZA200604365B (en) 2003-11-20 2004-11-17 Compositions and methods for the diagnosis and treatment of tumor

Country Status (9)

Country Link
US (4) US20050208523A1 (fr)
EP (1) EP1694864A2 (fr)
JP (1) JP2007512019A (fr)
KR (1) KR20060116834A (fr)
AU (1) AU2004293787A1 (fr)
CA (1) CA2546428A1 (fr)
MX (1) MXPA06005672A (fr)
WO (1) WO2005052191A2 (fr)
ZA (1) ZA200604365B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137890A1 (en) 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2007087412A2 (fr) * 2006-01-25 2007-08-02 Thallion Pharmaceuticals, Inc. Tat-036 et méthodes d'évaluation et de traitement du cancer
US20090011060A1 (en) * 2007-07-06 2009-01-08 Peter Koepke Campsiandra angustifolia extract and methods of extracting and using such extract
US7879369B2 (en) 2007-09-18 2011-02-01 Selvamedica, Llc Combretum laurifolium Mart. extract and methods of extracting and using such extract
US10260089B2 (en) 2012-10-29 2019-04-16 The Research Foundation Of The State University Of New York Compositions and methods for recognition of RNA using triple helical peptide nucleic acids

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5932211A (en) * 1991-11-12 1999-08-03 Women's And Children's Hospital Glycosylation variants of iduronate 2-sulfatase
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US20030004311A1 (en) * 1997-06-18 2003-01-02 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20020137890A1 (en) * 1997-03-31 2002-09-26 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO1999033963A1 (fr) * 1997-12-31 1999-07-08 Chiron Corporation Gene regule par cancer metastatique
US6562956B1 (en) * 1999-09-23 2003-05-13 Trustees Of The University Of Pennsylvania Identification and cloning of a new subfamily of sulfatases and functional embryonic techniques for characterization of such proteins
US20030148920A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof
US20030147875A1 (en) * 2000-12-27 2003-08-07 Steven Rosen Sulfatases and methods of use thereof

Also Published As

Publication number Publication date
WO2005052191A8 (fr) 2005-09-01
EP1694864A2 (fr) 2006-08-30
CA2546428A1 (fr) 2005-06-09
US20080096215A1 (en) 2008-04-24
US20070254302A1 (en) 2007-11-01
AU2004293787A1 (en) 2005-06-09
MXPA06005672A (es) 2006-08-17
JP2007512019A (ja) 2007-05-17
WO2005052191A2 (fr) 2005-06-09
US20050208523A1 (en) 2005-09-22
KR20060116834A (ko) 2006-11-15
US20050164250A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
EP1571968A4 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
EP1589933A4 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
EP1572091A4 (fr) Compositions et methodes de diagnostic et de traitement de tumeurs
EP1553912A4 (fr) Compositions et methodes pour le diagnostic et pour le traitement d'une tumeur
EP1578996A4 (fr) Compositions et methodes pour diagnostiquer et traiter des tumeurs
WO2004030615A8 (fr) Compositions et procedes de diagnostic et de traitement de tumeur
WO2004016225A8 (fr) Compositions et methodes de diagnostic et de traitement des tumeurs
EP1571968A3 (fr) Compositions et methodes permettant de diagnostiquer et de traiter une tumeur
EP1575571A4 (fr) Compositions et methodes de diagnostic et de traitement d'une tumeur
EP1572091A3 (fr) Compositions et methodes de diagnostic et de traitement de tumeurs
EP1814909A4 (fr) Utilisation de aimp2dx2 pour diagnostiquer et traiter un cancer
AU2003302892A8 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
EP1663259A4 (fr) Compositions et methodes de traitement du cancer
AU2003300368A8 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
IL162201A0 (en) New methods for diagnosis and treatment of tumours
AU2003286741A8 (en) Methods and compositions for diagnosis and therapy of parkin-associated disorders
AU2003290605A8 (en) Compositions and methods for the diagnosis and treatment of sepsis
ZA200510282B (en) Compositions and methods for the diagnosis and treatment of tumor
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
EP1680145A4 (fr) Methodes et compositions pour le traitement de maladies neurologiques
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003237792A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1606418A4 (fr) Methodes de diagnostic et de traitement de l'epilepsie
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1797430A4 (fr) Methodes et compositions de diagnostic et de traitement du cancer